Bernard Canaud

Professor Bernard Canaud is currently Emeritus Professor of Nephrology at the Montpellier University School of Medicine. He had workeat Lapeyronie Hospital, Univeristy Teaching Hospital, Montpellier, France from 1990 to 2012. He was made Head of the Nephrology department in 1998, and since 2002 has also held the position of Head of AIDER (Association pour L’Installation à Domicile des Epurations Rénales), a regional non-profit association for end-stage renal disease and held this position until May 2012. Professor Canaud graduated in Medicine from the Montpellier Medical School in 1980 and went on to specialize in Nephrology in 1981. He went on to receive his Master of Science doctorate in Food and Nutrition from the University of Sciences, Montpellier in 1986. Meanwhile, Professor Canaud held the positions of Assistant in Critical Care Medicine from 1981 to 1984 and Assistant Professor of Nephrology from 1984 to 1988 at Montpellier University. Professor Canaud served as chairman and Chief Medical Officer at FMC Germany medical board from May 2012 to December 2018 for the region of Europe, Middle-East, Africa and Latin America. From January 2019, he has been appointed Chief Medical Scientist within the Global Medical Office of FMC corporate. Professor Canaud serves on the Editorial Board of many journals including Néphrologie & Thérapeutique, Journal of Nephrology, Blood Purification, American Journal of Kidney Diseases, Clinical Nephrology, Kidney International, Journal of the American Society of Nephrology, Journal of Vascular Access, Hemodialysis International, Portuguese Journal of Nephrology and Hypertension and Nephrology Dialysis Transplantation. He is also a member of many societies including the European Dialysis and Transplant Association (EDTA), the American Society of Nephrology (ASN), the International Society of Nephrology (ISN) and the French Society of Nephrology. He is past president of the Société Francophone de Dialyse (SFD). He was past president of the Association pour Installation à Domicile des Epurations Rénales (AIDER) a non-profit association that cares for chronic kidney patients on renal replacement therapy. He created an institute for dialysis training and research as IRFD “Institut de Recherche et Formation en Dialyse”. He contributed to the elaboration and production of the European Best Practice Guidelines particularly on dialysis fluid purity, vascular access, dialysis adequacy and anemia management. He is in charge of the EUDIAL working group dedicated to the improvement of outcome in dialysis dependent patients. He has published more than 350 peered review manuscripts, contributed in more than 70 textbook chapters and attended more than 1000 scientific medical meetings. Professor Canaud has patent on catheter and implantable port catheter devices for dialysis. Professor Canaud’s research interests lie across the area of nephrology and, to name but a few, include development of extracorporeal treatment modalities, dialysis quantification (on-line and off-line monitoring), vascular access development (temporary and permanent catheters), nutritional assessment and support for renal patients, biocompatibility of dialysis systems, uremic toxins removal, metabolic and inflammatory mediators identification, lipids and oxidative stress disorders, vascular calcification, treatment modalities for acute renal patients, and erythropoietin evaluation and modeling. Professor Canaud received several awards and distinctions from international nephrology societies including the prestigious Belding Scribner award from the ISHD at Seattle on March 6, 2010. He received also from the French President on November 4, 2009 the “Légion d’Honneur” as recognition for his lifetime of medical achievement in renal field and received from the Annual Dialysis Conference the lifetime achiement award in March 2019. Professor Canaud acts as Chief Medical Scientist for FMC within the Global Medical Office.